Morganite Crucible India Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
- April 24, 2026
- Posted by: Neeraj Pandey
- Category: News
Morganite Crucible India (MORGANITE) Q4 results for FY26 are expected in June 2026. With Q3 FY26 revenue of Rs 42 Cr and PAT of Rs 15 Cr as the base, the street is watching closely for margin trajectory and management guidance on FY27 demand.
Get Free SEBI-Registered Research on Morganite Crucible India — Click Here
Morganite Crucible India Q4 FY26 Earnings Preview — What to Expect
India’s specialty chemicals sector is in recovery mode in Q4 FY26, with global inventory destocking cycles ending and China Plus One sourcing creating new export order flows for Indian manufacturers with quality approvals.
Morganite Crucible India Q4 Results 2026 — Date and Key Estimates
| Parameter | Q3 FY26 Actual | Q4 FY26 Estimate | YoY Growth |
|---|---|---|---|
| Revenue (Rs Cr) | 42 | 46 | +10% |
| PAT (Rs Cr) | 15 | 17 | +13% |
| EBITDA Margin | — | 37.0% | Improvement expected |
| Results Date | — | June 2026 | — |
| Dividend History | Rs 25.00 per share | ||
| Dividend Expectation | Rs 30.00 final dividend expected | ||
Estimates based on analyst consensus as of April 2026. Actual results may vary. Verify before investing.
Track Morganite Crucible India live price, FII/DII activity and fundamentals on Univest Screener
5 Reasons Morganite Crucible India Q4 Results Could Beat Estimates
Export Demand Recovery Post Destocking
Global chemical destocking cycles are drawing to a close. European and US buyers are resuming regular procurement from Indian specialty chemical suppliers, with order flow normalising across agrochemical intermediates and fine chemicals.
Agrochemical Market Uptick
Global agrochemical demand recovery is benefiting Indian manufacturers of intermediates and technical actives as channel inventories normalise and planting season demand picks up globally.
China Plus One Sourcing Shift
Continued strategic diversification away from China by global chemical multinationals is creating new long-term supply agreements for Indian players with REACH and other regulatory approvals.
Capacity Utilisation Improvement
New capacities commissioned in FY24-25 are now ramping up, improving fixed cost absorption and enabling meaningful operating leverage on recovering volumes.
Product Mix Premiumisation toward CDMO
Companies focusing on fine chemicals, CDMO services and performance materials are seeing better realisation and superior margins compared to commodity chemical peers.
5 Key Risks to Watch in Morganite Crucible India Q4 Results
China Dumping Risk
Chinese chemical producers with excess capacity may resort to aggressive pricing in global markets, pressuring Indian exporters on both volume and margins.
Agrochemical Market Cyclicality
Oversupply or poor monsoon seasons can rapidly reverse agrochemical demand conditions for intermediates and actives manufacturers.
Environmental Compliance Costs
Stringent REACH standards in Europe and domestic environmental regulations add compliance and capital investment costs.
Customer Concentration
Dependence on a few large global clients creates revenue vulnerability to sourcing strategy shifts or relationship disruptions.
Energy Cost Sensitivity
Specialty chemical manufacturing is energy-intensive; power and fuel cost fluctuations directly impact production margins.
Analyst Ratings and Target Price for Morganite Crucible India
| Brokerage | Rating | Key Thesis |
|---|---|---|
| ICICI Direct | Buy | Export recovery and China Plus One structural benefit |
| Motilal Oswal | Neutral | Gradual recovery; watch margin trajectory |
| JM Financial | Buy | Volume ramp-up and operating leverage materialising |
Analyst ratings are for informational purposes only and subject to change. Not investment advice.
Q4 Results 2026 Calendar — Key Dates to Track
| Company | Expected Results Date |
|---|---|
| Morganite Crucible India | June 2026 |
| TCS | April 2026 |
| Infosys | April 2026 |
Stay updated on all Q4 FY26 earnings at Univest Blogs. For TCS results see TCS Q4 Results 2026 and for Infosys see Infosys Q4 Results 2026.
How to Invest in Morganite Crucible India Based on Q4 Results
Before investing in Morganite Crucible India based on Q4 results, consider the following approach: review the actual revenue and PAT versus analyst estimates, listen to the management earnings call for FY27 guidance, assess whether the EBITDA margin trajectory is improving or deteriorating, and check FII/DII activity patterns post-results. A beat on estimates with positive guidance is typically a bullish signal; a miss with downgraded guidance may indicate further correction risk.
Frequently Asked Questions — Morganite Crucible India Q4 Results 2026
Q: When will Morganite Crucible India announce Q4 FY26 results?
Morganite Crucible India (MORGANITE) is expected to announce Q4 FY26 results in June 2026. The exact board meeting date will be communicated via BSE/NSE exchange filing. Track the date on Univest Screener.
Q: What is the revenue estimate for Morganite Crucible India Q4 FY26?
Analyst consensus estimates Morganite Crucible India Q4 FY26 revenue at approximately Rs 46 Cr, representing approximately 10% year-on-year growth. The actual number will depend on sector demand trends and execution in the quarter.
Q: What PAT is expected for Morganite Crucible India in Q4 FY26?
Estimated PAT for Morganite Crucible India Q4 FY26 is approximately Rs 17 Cr, up approximately 13% year-on-year. Margin expansion from operating leverage and input cost moderation are the primary drivers of profit growth expectations.
Q: Will Morganite Crucible India declare a dividend in Q4 FY26?
Historical dividend pattern for Morganite Crucible India: Rs 25.00 per share. For Q4 FY26, Rs 30.00 final dividend expected. Dividend declarations are subject to board approval at the time of results.
Q: What is the current share price and market cap of Morganite Crucible India?
Morganite Crucible India (MORGANITE) is currently trading at approximately Rs 3280 with a market capitalisation of Rs 420 Cr. Track live price, volume and FII/DII data on Univest Screener.
Q: What are the key risks for Morganite Crucible India in Q4 FY26?
Key risks include: China Dumping Risk, Agrochemical Market Cyclicality, Environmental Compliance Costs. Investors should monitor management commentary on these risks in the Q4 earnings call.
Q: Is Morganite Crucible India a buy before Q4 results?
This article does not constitute investment advice. Whether to buy Morganite Crucible India before Q4 results depends on your risk appetite, existing portfolio exposure and entry price relative to fair value. Consult a SEBI-registered financial advisor before making any investment decision.
Q: How can I track Morganite Crucible India Q4 results live?
Track Morganite Crucible India Q4 FY26 results live on the Univest Screener, which provides real-time price updates, financial data and analyst research. Download the Univest iOS App or Android App for mobile alerts.
Disclaimer: Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered financial advisor before making any investment decisions. SEBI Registration: INH000012449.
Recent Article
Kridhan Infra Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Krebs Biochemicals and Industries Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
KRBL Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
KPIT Technologies Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Kothari Sugars and Chemicals Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
